Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

SciProfiles: 1627772

Activities

Collapse all

Employment (1)

Johnson & Johnson: Beerse, Antwerp, BE

2010-11-16 to present | Scientist (Infectious Diseases and Vaccines)
Employment
Source: Self-asserted source
Dorien De Pooter

Education and qualifications (4)

Universiteit Antwerpen: Antwerpen, BE

2022-09 to present | PhD (Pharmaceutical, biomedical and veterinary sciences)
Education
Source: Self-asserted source
Dorien De Pooter

Thomas More: Geel, BE

2011 | Felasa B
Education
Source: Self-asserted source
Dorien De Pooter

Group T : Leuven, BE

2005-09 to 2009-06 | Master (Industrial Sciences Biochemistry)
Education
Source: Self-asserted source
Dorien De Pooter

SILA: Westerlo, BE

2004 (Languages-Mathematics (8h))
Education
Source: Self-asserted source
Dorien De Pooter

Works (8)

Preclinical evaluation of therapeutic pDNA and mRNA vaccines for chronic hepatitis B

2024 | Dissertation or Thesis
DOI: 10.63028/10067/2067390151162165141
Source: check_circle
Crossref

mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model

Vaccines
2024-02-25 | Journal article
DOI: 10.3390/vaccines12030237
Contributors: Dorien De Pooter; Wim Pierson; Soheil Pourshahian; Koen Dockx; Ben De Clerck; Isabel Najera; Heather Davis; Ellen Van Gulck; Daniel Boden
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels

Vaccines
2023-12 | Journal article | Author
DOI: 10.3390/vaccines11121825
Contributors: Nádia Conceição-Neto; Wim Pierson; Maurizio Vacca; Matthias Beyens; Ben De Clerck; Liese Aerts; Birgit Voeten; Dorien De Pooter; Lore Verschueren; Koen Dockx et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A Therapeutic Hepatitis B Virus DNA Vaccine Induces Specific Immune Responses in Mice and Non-Human Primates

Vaccines
2021-08-29 | Journal article
DOI: 10.3390/vaccines9090969
Part of ISSN: 2076-393X
Contributors: Dorien De Pooter; Ellen Van Gulck; Antony Chen; Claire F. Evans; Jean-Marc Neefs; Helen Horton; Daniel Boden
Source: Self-asserted source
Dorien De Pooter

2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus

Journal of Medicinal Chemistry
2018-07-26 | Journal article
DOI: 10.1021/acs.jmedchem.8b00643
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Contributors: Werner Embrechts; Florence Herschke; Frederik Pauwels; Bart Stoops; Stefaan Last; Serge Pieters; Vineet Pande; Geert Pille; Katie Amssoms; Ilham Smyej et al.
Source: Self-asserted source
Dorien De Pooter

Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists

Bioorganic & Medicinal Chemistry Letters
2018-02 | Journal article
DOI: 10.1016/j.bmcl.2018.01.014
Part of ISSN: 0960-894X
Contributors: Serge Pieters; David McGowan; Florence Herschke; Frederik Pauwels; Bart Stoops; Stefaan Last; Werner Embrechts; Annick Scholliers; Wendy Mostmans; Kris Van Dijck et al.
Source: Self-asserted source
Dorien De Pooter

Identification and Optimization of Pyrrolo[3,2-<i>d</i>]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B

Journal of Medicinal Chemistry
2017-07-27 | Journal article
DOI: 10.1021/acs.jmedchem.7b00365
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Contributors: David McGowan; Florence Herschke; Frederik Pauwels; Bart Stoops; Ilham Smyej; Stefaan Last; Serge Pieters; Werner Embrechts; Mourad Daoubi Khamlichi; Tine Thoné et al.
Source: Self-asserted source
Dorien De Pooter

Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus

Journal of Medicinal Chemistry
2016-09-08 | Journal article
DOI: 10.1021/acs.jmedchem.6b00747
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Contributors: David McGowan; Florence Herschke; Frederik Pauwels; Bart Stoops; Stefaan Last; Serge Pieters; Annick Scholliers; Tine Thoné; Bertrand Van Schoubroeck; Dorien De Pooter et al.
Source: Self-asserted source
Dorien De Pooter
How many people are using ORCID?